Coronary Artery Disease

Clinical Trial Finder

Many patients with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease

Condition:   Ischemic Heart Disease
Interventions:   Drug: GS-6615;   Drug: Placebo
Sponsor:   Gilead Sciences
Not yet recruiting - verified February 2015

Bile Acids and Gut Microbiota as Potent Coronary Atheroma Risk Factors: a Prospective Study in Human

Condition:   Coronary Disease
Interventions:   Other: No intervention;   Other: Healthy subject
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting - verified February 2015

Pd/Pa vs iFR in an Unselected Population Referred for Invasive Angiography

Conditions:   Coronary Artery Disease;   Plaque;   Atherosclerosis;   Coronary Physiology
Intervention:  
Sponsor:   Golden Jubilee National Hospital
Recruiting - verified February 2015

Regional Activation of Leukocytes in Coronary Artery Disease

Conditions:   Inflammation;   Coronary Artery Disease
Intervention:  
Sponsor:   Sint Franciscus Gasthuis
Completed - verified February 2015

Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation

Conditions:   Inflammation Plaque, Atherosclerotic;   Coronary Disease;   Renin-Angiotensin System
Intervention:   Drug: 6-month treatment
Sponsors:   CHEOL WHAN LEE, M.D., Ph.D;   Boryung Pharmaceutical Co., Ltd
Not yet recruiting - verified February 2015

Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium

Condition:   Atherosclerosis
Interventions:   Drug: rivaroxaban;   Drug: Warfarin
Sponsor:   Los Angeles Biomedical Research Institute
Recruiting - verified February 2015

Benefits of Exercise Training in Women With Ischemic Syndrome

Condition:   Microvascular Coronary Dysfunction
Intervention:   Behavioral: Exercise training
Sponsor:   Cedars-Sinai Medical Center
Not yet recruiting - verified February 2015

Examining How Chronic Health States and Acute Treatment Contribute to Variations in AMI Mortality Across the English NHS

Condition:   Myocardial Infarction
Intervention:   Other: Standard Hospital Care
Sponsor:   London School of Economics and Political Science
Active, not recruiting - verified February 2015

PCA062 in pCAD-positive Tumors

Condition:   Triple Negative Breast Cancer, Head & Neck Cancer, Esophageal Cancer
Intervention:   Drug: PCA062
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting - verified February 2015

Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease

Condition:   Cardiovascular Disease
Interventions:   Drug: Aspirin;   Drug: Durlaza™
Sponsor:   New Haven Pharmaceuticals, Inc.
Recruiting - verified February 2015

Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy

Condition:   Cardiac Allograft Vasculopathy
Intervention:   Device: Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)
Sponsor:   Universita di Verona
Recruiting - verified February 2015

Very Brief Smoking Reduction Intervention

Condition:   Smoking Cessation
Interventions:   Behavioral: Smoking reduction intervention;   Behavioral: Exercise and diet advice control
Sponsor:   Chinese PLA General Hospital
Not yet recruiting - verified February 2015

Physical and Functional Recovery From Cardiac Surgery in Hospitalized Patients: A Feasibility Pilot Study

Conditions:   Coronary Artery Disease;   Mitral Valve Insufficiency;   Aortic Valve Stenosis;   Aortic Valve Regurgitation;   Mitral Valve Stenosis;   Coronary Artery Bypass Graft Triple Vessel
Intervention:   Procedure: Ambulation orderly
Sponsors:   Baystate Medical Center;   Springfield College
Not yet recruiting - verified February 2015

Early Use of TIPSS in Patients With Cirrhosis and Variceal Bleeding

Conditions:   Liver Cirrhosis;   Variceal Haemorrhage
Interventions:   Procedure: Endoscopic Variceal Band Ligation;   Procedure: Transjugular Intrahepatic Porto-Systemic Stent Shunt
Sponsors:   University of Edinburgh;   NHS Lothian
Recruiting - verified February 2015

Saxagliptin and Acute Myocardial Infarction:Effects on Platelet Function

Condition:   Platelet Aggregation During Acute Myocardial Infarction
Interventions:   Drug: saxagliptin;   Drug: placebo
Sponsors:   University of Sao Paulo General Hospital;   Heart Institute (InCor) University of São Paulo Medical School
Not yet recruiting - verified December 2014

Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting

Condition:   Coronary Artery Disease
Intervention:   Other: Sonolysis
Sponsor:   University Hospital Ostrava
Not yet recruiting - verified March 2015

Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X: New Insights Into the Pathophysiology

Conditions:   Syndrome X;   Takotsubo Cardiomyopathy
Intervention:   Other: BaroReflex Sensitivity, endothelial function measurement
Sponsor:   Ospedale San Giovanni Bellinzona
Active, not recruiting - verified December 2014

Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension

Condition:   Acute Coronary Syndromes
Intervention:  
Sponsor:   AstraZeneca
Recruiting - verified March 2015

A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Acetylsalicylic acid;   Drug: Rivaroxaban;   Drug: Clopidogrel;   Drug: Ticagrelor
Sponsors:   Janssen Research & Development, LLC;   Bayer;   Duke Clinical Research Institute;   Harvard Medical School
Not yet recruiting - verified February 2015

Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

Condition:   Cardiogenic Shock
Intervention:   Device: HeartMate PHP
Sponsor:   Thoratec Corporation
Recruiting - verified February 2015

Computed Tomography (CT) Coronary Angiogram Evaluation in Cancer Patients Having CT Thorax, Abdomen and Pelvis

Condition:   Coronary Stenosis
Intervention:   Radiation: CT TAP Scan
Sponsor:   Plymouth Hospitals NHS Trust
Not yet recruiting - verified February 2015

Radial Artery Clamp Times in Patients Undergoing Cardiac Catheterization Via Transradial Approach

Condition:   Coronary Artery Disease
Interventions:   Device: Vascular compression device- RADAR TM-Short clamp time;   Device: Vascular compression device RADAR TM-Long clamp time
Sponsor:   Lawson Health Research Institute
Recruiting - verified March 2015

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Conditions:   Stroke;   Secondary Prevention
Interventions:   Drug: optional ASA as comedication;   Drug: placebo to ASA;   Drug: placebo to optional ASA as comedication;   Drug: placebo to dabigatran etexilate;   Drug: ASA 100 mg;   Drug: dabigatran etexilate
Sponsor:   Boehringer Ingelheim
Recruiting - verified February 2015

Exploring the Mechanism of the Plaque Rupture in Acute Myocardial Infarction

Conditions:   Acute Coronary Syndrome;   Myocardial Infarction;   Plaque, Atherosclerotic;   Rupture, Spontaneous
Intervention:  
Sponsors:   Seoul National University Hospital;   HeartFlow, Inc.;   Kyoto University, Graduate School of Medicine;   Inje University;   Keimyung University Dongsan Medical Center;   Ulsan University Hospital;   Wakayama Medical University;   Aarhus University Hospital
Recruiting - verified February 2015

Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction

Conditions:   ST-segment Elevation Myocardial Infarction;   Non-ST-segment Elevation Myocardial Infarction;   VA Drug Interactions [VA Drug Interaction]
Interventions:   Drug: Morphine;   Drug: Placebo;   Drug: Ticagrelor
Sponsor:   Collegium Medicum w Bydgoszczy
Recruiting - verified February 2015

Comparison Between Moderate-high Interval Exercise and Moderate Continuous Exercise in an Advanced Cardiac Rehabilitation Program

Conditions:   Coronary Artery Disease;   Myocardial Infarction
Interventions:   Other: Interval exercise training;   Other: Continuous exercise training
Sponsor:   Assaf-Harofeh Medical Center
Recruiting - verified February 2015

Paraoxonase and HDL Qualities in Glycaemia and Inflammation

Conditions:   Diabetes.;   Bariatric Surgery.
Intervention:  
Sponsors:   Central Manchester University Hospitals NHS Foundation Trust;   British Heart Foundation;   Juvenile Diabetes Research Foundation
Recruiting - verified February 2015

Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking

Condition:   Ischemia
Intervention:   Drug: Regadenoson
Sponsors:   M.D. Anderson Cancer Center;   Astellas Scientific & Medical Affairs, Inc.
Recruiting - verified March 2015

A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Losmapimod 7.5 mg twice daily;   Drug: Placebo twice daily
Sponsors:   GlaxoSmithKline;   The TIMI Study Group
Recruiting - verified February 2015

Medication Adherence and "True" Resistance in Patients With Resistant Hypertension

Conditions:   Hypertensive Disease;   Hypertension, Resistant to Conventional Therapy
Intervention:  
Sponsor:   Charite University, Berlin, Germany
Recruiting - verified February 2015

Carnitine for the Treatment of Atherosclerosis.

Condition:   Metabolic Syndrome
Interventions:   Dietary Supplement: L-carnitine capsules;   Dietary Supplement: Lactose capsules
Sponsors:   Queen's University;   Heart and Stroke Foundation of Canada
Recruiting - verified March 2015

Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function

Condition:   ST-Segment Elevation Myocardial Infarction
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel
Sponsor:   Jinan Central Hospital
Not yet recruiting - verified February 2015

Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol

Conditions:   Aortic Valve Disease;   Coronary Artery Disease (CAD)
Interventions:   Drug: Custodiol-N;   Drug: Custodiol
Sponsor:   Dr. F. Köhler Chemie GmbH
Recruiting - verified February 2015

A Phase II Study of Androgen Deprivation Therapy With or Without PD 0332991 in RB-Positive Metastatic Prostate Cancer

Condition:   Prostate Cancer
Interventions:   Drug: PD 0332991;   Drug: Bicalutamide;   Drug: Zoladex;   Drug: Lupron Depot
Sponsors:   University of Michigan Cancer Center;   University of Utah;   Vanderbilt-Ingram Cancer Center;   Dana-Farber Cancer Institute;   Johns Hopkins University;   Thomas Jefferson University
Recruiting - verified February 2015

CO2 as a Stress Agent for Perfusion Imaging

Condition:   Coronary Artery Disease
Interventions:   Device: Delivery of precise levels of carbon dioxide with the RespirAct™ Gen4 sequential gas delivery system;   Device: Delivery of rubidium radioisotope (Rb-82) using the automated pump/elution system
Sponsor:   Ottawa Heart Institute Research Corporation
Recruiting - verified February 2015

A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Ticagrelor 90 mg;   Drug: Ticagrelor placebo
Sponsor:   AstraZeneca
Recruiting - verified February 2015

COOL-AMI EU Case Series Clinical Study

Condition:   Acute Myocardial Infarction
Intervention:  
Sponsor:   ZOLL Circulation, Inc., USA
Recruiting - verified March 2015

The PzF Shield Trial

Condition:   Coronary Artery Disease
Intervention:   Device: COBRA PzF
Sponsor:   CeloNova BioSciences, Inc.
Active, not recruiting - verified February 2015

Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome

Condition:   Acute Coronary Syndrome
Intervention:  
Sponsor:   AstraZeneca
Recruiting - verified February 2015

Resolute Integrity US Extended Length Sub-Study(RI-US XL)

Condition:   Coronary Artery Disease
Intervention:   Device: Resolute Integrity Stent
Sponsor:   Medtronic Vascular
Recruiting - verified March 2015

Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients

Condition:   Hiv Infection
Intervention:   Biological: blood sampling,
Sponsor:   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting - verified February 2015

Renal Denervation in Patients After Acute Coronary Syndrome

Conditions:   Acute Coronary Syndrome;   Arterial Hypertension
Interventions:   Procedure: Renal denervation;   Drug: Metoprolol;   Drug: Lisinopril
Sponsor:   Meshalkin Research Institute of Pathology of Circulation
Recruiting - verified February 2015

A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure

Conditions:   Heart Failure;   Coronary Artery Disease
Interventions:   Drug: Rivaroxaban;   Drug: Placebo;   Other: Standard of care for heart failure and coronary artery disease
Sponsors:   Janssen Research & Development, LLC;   Bayer
Recruiting - verified February 2015

The Effectiveness of the Care Programme for the Last Days of Life

Condition:   Older Patients Dying in Acute Geriatric Hospital Wards
Intervention:   Other: Care Programme for the Last Days of Life
Sponsors:   End-of-Life Research Group;   Agentschap voor Innovatie door Wetenschap en Technologie;   Katholieke Universiteit Leuven;   VU University Medical Center;   University Ghent;   Vrije Universiteit Brussel
Recruiting - verified February 2015

The TRUST Study - Depression Substudy

Conditions:   Subclinical Hypothyroidism;   Depression
Interventions:   Drug: Levothyroxine;   Drug: Placebo
Sponsors:   University Hospital Inselspital, Berne;   Leiden University Medical Center;   University of Bern
Recruiting - verified February 2015

Propofol Effects on Mitral Valve Annular Velocity

Conditions:   Valvular Heart Disease;   Coronary Artery Disease
Intervention:   Drug: propofol
Sponsor:   Konkuk University Medical Center
Recruiting - verified March 2015

Ticagrelor vs Clopidogrel Effect on MFR in CAD Population

Condition:   Coronary Artery Disease
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel
Sponsor:   Ottawa Heart Institute Research Corporation
Active, not recruiting - verified March 2015

Neurological Complications Comparing Endoscopically vs. Open Harvest of the Radial Artery

Conditions:   Complications Due to Coronary Artery Bypass Graft;   Coronary Artery Disease;   Myocardial Ischemia;   Coronary Disease;   Heart Diseases;   Cardiovascular Diseases;   Arteriosclerosis;   Arterial Occlusive Diseases;   Vascular Diseases
Interventions:   Procedure: Endoscopic radial artery harvest;   Procedure: Open radial artery harvest;   Procedure: Mammarioradial graft (Y-graft);   Procedure: Aortoradial graft (Free RA)
Sponsor:   Rigshospitalet, Denmark
Recruiting - verified February 2015

Comparison of the Efficacy and Safety of Closone and Clopidogrel With Aspirin

Condition:   Coronary Artery Disease
Interventions:   Drug: Closone;   Drug: Plavix with Astrix
Sponsor:   Seoul St. Mary's Hospital
Completed - verified February 2015

ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.

Conditions:   Chronic Total Occlusion of Coronary Artery;   Coronary Occlusion;   Coronary Artery Disease;   Coronary Artery Restenosis;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Restenosis
Intervention:   Device: Absorb Bioresorbable Vascular Scaffold
Sponsor:   Abbott Vascular
Active, not recruiting - verified February 2015

DETErmination of the Duration of the Dual Antiplatelet Therapy by the Degree of the Coverage of The Struts on Optical Coherence Tomography From the Randomized Comparison Between Everolimus-eluting Stents(EES) Versus Biolimus A9-eluting Stents(BES)

Condition:   Ischemic Heart Disease
Interventions:   Device: Angio-guided PCI with EES  or BES;   Device: OCT-guided PCI with EES  or BES;   Device: PCI with BES under angio-guide or OCT guide;   Device: PCI with EES under angio-guide or OCT guide;   Drug: Keep DAPT;   Drug: Discontinue DAPT
Sponsor:   Yonsei University
Recruiting - verified February 2015

Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease

Condition:   Refractory Cold Agglutinin Disease
Intervention:   Drug: Bortezomib
Sponsor:   Gruppo Italiano Malattie EMatologiche dell'Adulto
Recruiting - verified February 2015

A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: aleglitazar;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

AngioSeal Versus Radial Approach in Acute Coronary Syndrome

Condition:   Acute Coronary Syndrome
Intervention:   Device: Percutaneous coronary intervention
Sponsor:   Irmandade Santa Casa Misericórdia Marília
Active, not recruiting - verified March 2015

Tryptase and Coronary Heart Disease

Conditions:   Acute Coronary Syndrome With ST Elevation on Electrocardiogram;   Acute Coronary Syndrome Without ST Elevation on Electrocardiogram;   Noncritical Coronary Artery Disease With Coronary Stenosis <50%;   Aortic Aneurysms
Intervention:  
Sponsor:   Niguarda Hospital
Recruiting - verified February 2015

A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Brilinta

Condition:   Acute Coronary Syndromes
Intervention:  
Sponsor:   AstraZeneca
Recruiting - verified February 2015

CHANGE -it is About Life

Conditions:   Schizophrenia;   Metabolic Syndrome
Interventions:   Other: Treatment as usual;   Behavioral: Care coordinator;   Behavioral: CHANGE
Sponsors:   Mental Health Services in the Capital Region, Denmark;   University of Copenhagen
Active, not recruiting - verified March 2015

Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Modification of Prasugrel based on a biological assay;   Drug: prasugrel / clopidogrel;   Device: Verify Now
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Eli Lilly and Company;   Daiichi Sankyo Inc.;   Allies in Cardiovascular Trials Initiatives and Organized Networks:ACTION;   Accumetrics, Inc.;   Stentys
Recruiting - verified February 2015

Primary Reperfusion Secondary Stenting Trial

Condition:   ST-elevation Myocardial Infarction
Intervention:   Procedure: Percutaneous coronary intervention
Sponsor:   Montreal Heart Institute
Recruiting - verified February 2015

Radial Artery Access With Ultrasound Trial

Condition:   Coronary Artery Disease
Interventions:   Procedure: Ultrasound guidance;   Procedure: Palpation
Sponsors:   University of California, Irvine;   Lenox Hill Hospital;   Jamaica Hospital Medical Center;   Oklahoma City VA Medical Center
Completed - verified February 2015

A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Condition:   Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Interventions:   Other: Background care;   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

Hybrid Revascularisation by Combined Coronary Artery Bypass Graft (CABG) and PCI in Multivessel Coronary Disease

Condition:   Coronary Artery Disease (CAD)
Interventions:   Procedure: LIMA-LAD surgical revascularization;   Procedure: PCI
Sponsor:   Ettore Sansavini Health Science Foundation
Recruiting - verified February 2015

Clinical Registry on Sudden Death Primary Prevention at Latin America

Conditions:   Myocardial Infarction;   Sudden Death
Intervention:   Procedure: Implantable Cardio Defibrillator (ICD),
Sponsor:   Biotronik SE & Co. KG
Withdrawn - verified March 2015

Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow up

Conditions:   Diabetes Mellitus;   Hypertension;   Ischemic Heart Disease;   Stroke
Intervention:  
Sponsor:   Oslo University Hospital
Active, not recruiting - verified February 2015

Management of New-Onset Postoperative Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Coronary Artery Disease;   Post Operative Arrythmia
Intervention:  
Sponsors:   Emory University;   Medtronic
Recruiting - verified February 2015

"ESTIMATION Study" for Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction

Conditions:   Acute Myocardial Infarction;   Heart Failure
Intervention:   Procedure: PCI and Stem Cells or Placebo injections
Sponsor:   Meshalkin Research Institute of Pathology of Circulation
Recruiting - verified February 2015

REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction

Condition:   Acute Myocardial Infarction
Intervention:   Drug: Aspirin 200mg qd, Clopidogrel 2x75mg qd
Sponsor:   University Hospital Ostrava
Recruiting - verified February 2015

Resolute Zotarolimus-Eluting Stent Versus the Taxus Liberte Paclitaxel-Eluting Stent for Percutaneous Coronary Intervention in China

Conditions:   Ischemic Heart Disease;   Stenotic Coronary Lesion;   Cardiovascular Diseases;   Arteriosclerosis;   Coronary Artery Disease
Interventions:   Device: Taxus Liberte Paclitaxel-Eluting Coronary Stent System;   Device: Resolute Zotarolimus-Eluting Coronary Stent System
Sponsor:   Medtronic Vascular
Active, not recruiting - verified March 2015

A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)

Condition:   Coronary Heart Disease
Interventions:   Drug: dalcetrapib;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention

Condition:   Myocardial Infarction
Interventions:   Procedure: Percutaneous Coronary Intervention (PCI);   Drug: RO4905417;   Drug: RO4905417;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Real-World Patient Population in China

Conditions:   Ischemic Heart Disease;   Stenotic Coronary Lesion;   Cardiovascular Diseases;   Arteriosclerosis;   Coronary Artery Disease
Intervention:  
Sponsor:   Medtronic Vascular
Active, not recruiting - verified March 2015

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Condition:   Coronary Heart Disease, Graft Occlusion, Vascular
Interventions:   Drug: Placebo;   Drug: RO4905417
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

Study to Monitor the Effects of Androgen Suppression Treatment on the Heart

Condition:   Prostate Cancer
Intervention:   Radiation: PET scan and ultrasound
Sponsor:   Ottawa Heart Institute Research Corporation
Active, not recruiting - verified March 2015

Imaging and Biomarkers of Atherosclerosis in Patients With Stable or Unstable Coronary Artery Disease

Conditions:   Atherosclerosis;   Coronary Artery Disease;   Acute Coronary Syndrome
Interventions:   Device: Coronary intervention using IVUS-VH & FDG PET-MDCT;   Device: Coronary intervention using IVUS-VH & FDG PET-MDCT
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Institut National de la Santé Et de la Recherche Médicale, France
Completed - verified February 2015

Atrial Fibrillation Registry for Ankle-brachial Index Prevalence Assessment: Collaborative Italian Study.

Conditions:   Atrial Fibrillation;   Peripheral Vascular Disease
Intervention:  
Sponsor:   University of Roma La Sapienza
Completed - verified February 2015

Fractional Flow Reserve and Intravascular Ultrasound RelationShip STudy

Condition:   Coronary Artery Disease
Intervention:  
Sponsor:   Volcano Corporation
Completed - verified January 2015

Physiopathology of Rapid Aspirin Desensitization

Conditions:   Hypersensitivity;   Coronary Artery Disease
Intervention:  
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed - verified February 2015

Meta-Analysis of Cell-based CaRdiac stUdiEs: ACCRUE

Condition:   Ischemic Heart Disease
Intervention:   Other: cell therapy
Sponsors:   Medical University of Vienna;   Nantes University Hospital;   Oslo University Hospital;   Medical University of Silesia;   Hannover Medical School;   Cardiovascular Research Center, Aalst, Belgium;   Cedars-Sinai Medical Center;   Johann Wolfgang Goethe University Hospitals;   University of Ulm;   Military Medical Academy, Belgrade, Serbia;   Novosibirsk Scientific Research Institute for Circulatory Pathology;   Rigshospitalet, Denmark;   Asklepios Kliniken Hamburg GmbH;   Leiden University Medical Center;   University of Debrecen;   University of Targu Mures, Romania;   University Clinic for Cardiology, Skopje, Republic of Macedonia;   State Health Center, Hungary;   Karolinska Institutet;   University of Zurich;   University of Oulu;   Odense University Hospital;   Minneapolis Heart Institute;   The University of Texas Health Science Center, Houston;   Klinik Hirslanden, Zurich;   University Hospital, Toulouse;   Heinrich-Heine University, Duesseldorf
Recruiting - verified March 2015

A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease

Condition:   Cardiovascular Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Terminated - verified March 2015

A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Aleglitazar;   Drug: Placebo
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

Non-Contact Measurement of Aortic Compliance

Condition:   Vascular Disease
Intervention:  
Sponsors:   Barts & The London NHS Trust;   National Institute for Health Research, United Kingdom
Completed - verified February 2015

Comparison of Cardiac Computed Tomography and Vasodilator Stress Magnetic Resonance Imaging Perfusion in Patients With Prior Equivocal Stress Test for Detection of Coronary Artery Disease

Conditions:   Myocardial Ischemia;   Coronary Artery Disease;   Myocardial Infarction
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified February 2015

Cardiovascular Disease Study

Condition:   Spinal Cord Injury
Interventions:   Procedure: 2 hour Oral Glucose Tolerance Test;   Procedure: Fat Meal Test
Sponsors:   Department of Veterans Affairs;   Kessler Foundation
Recruiting - verified February 2015

French Registry of Acute Coronary Syndrome

Condition:   Acute Myocardial Infarction
Intervention:   Other: Blood sample
Sponsors:   Assistance Publique - Hôpitaux de Paris;   French Cardiology Society
Active, not recruiting - verified October 2014

A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome

Condition:   Coronary Heart Disease
Interventions:   Drug: Evidence-based medical care for Acute Coronary Syndrome;   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

Examining How Heart Disease Risk Factors Affect Healthy Aging (The Chicago Healthy Aging Study [CHAS])

Conditions:   Coronary Disease;   Cardiovascular Diseases
Intervention:  
Sponsors:   Northwestern University;   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting - verified February 2015

Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique

Condition:   Coronary Arteriosclerosis
Intervention:   Device: OFDI  system
Sponsors:   Massachusetts General Hospital;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2015

Database Registry of the Intermountain Heart Collaborative Study

Conditions:   Coronary Artery Disease;   Electrophysiology;   Cardiovascular Disease
Intervention:  
Sponsor:   Intermountain Health Care, Inc.
Recruiting - verified February 2015

A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

Get CardioSmart

You're Invited